Hi everyone.
Great to see this trail. Adding few businesses that are projecting >20% growth in the next 2-3 years
-
Supriya Life sciences – INR 1,000 Cr revenue by FY27 (FY24 – 570 cr)
-
Muthoot Microfin – 25-30% growth for FY25
-
Sky Gold – INR 10,000 cr of revenue by FY27 (FY24 – 1745 cr)
-
Lincoln Pharma – 15-18% growth for next 2-3 years (P/E – 13x)
Would love to hear your thoughts on them.
| Subscribe To Our Free Newsletter |
